Darnytsia Registered a Medicine for the Treatment of Headache and Migraine in Georgia

Darnytsia Pharmaceutical Company has registered a medicine in Georgia that is used for the urgent treatment of headache and migraine attacks.

Georgia is not a member of the European Union; however, its legislative requirements for the registration of medicinal products are harmonized with EU standards. This once again proves that Ukrainian medicines are not inferior to foreign ones in terms of quality, efficacy, and safety.

It is worth noting that in 2024, the company received registration for 10 medicinal products outside of Ukraine and entered 6 new markets, including EU countries, Bosnia and Herzegovina, Israel, New Zealand, and Malaysia.

We would like to remind you that recently Darnytsia successfully registered a medicine in Georgia that is used for the treatment of severe traumatic brain injuries.

As of today, Darnytsia’s products are available in more than 20 countries worldwide.

"We have taken another important step towards expanding Darnytsia’s international presence and ensuring patients' access to effective Ukrainian medicines. 

The registration of our flagship headache product in Georgia is an important achievement for the company. The registration procedure for medicinal products in Georgia is supposed to take 210 days, but our team completed it in just 4 months. This is an incredible result," says Anna Pavliuk-Havrylova, Head of the Department of International Registration and Market Expansion at Darnytsia Pharmaceutical Company.